Fanconi anemia (FA) is a complex cancer susceptibility disorder associated with DNA repair defects and infertility, yet the precise function of the FA proteins in genome maintenance remains unclear. Here we report that C. elegans FANCD2 (fcd-2) is dispensable for normal meiotic recombination but is required in crossover defective mutants to prevent illegitimate repair of meiotic breaks by nonhomologous end joining (NHEJ). In mitotic cells, we show that DNA repair defects of C. elegans fcd-2 mutants and FA-deficient human cells are significantly suppressed by eliminating NHEJ. Moreover, NHEJ factors are inappropriately recruited to sites of replication stress in the absence of FANCD2. Our findings are consistent with the interpretation that FA results from the promiscuous action of NHEJ during DNA repair. We propose that a critical function of the FA pathway is to channel lesions into accurate, as opposed to error-prone, repair pathways.
INTRODUCTION
Fanconi anemia (FA) is a complex multigene disorder characterized by severe genome instability, congenital abnormalities, acute myeloid leukemia, and/or bone marrow failure and cancer predisposition (D'Andrea and Grompe, 2003; Fanconi, 1967; Kennedy and D'Andrea, 2005) . The hallmark of FA cells is exquisite sensitivity to interstrand crosslinking (ICL) agents, indicative of a repair defect in response to agents that block the replication fork. The FA pathway is composed of at least 13 proteins corresponding to the complementation groups found mutated in FA patients: FANCA, B, C, D1, D2, E, F, G, I, J, L, M, and N (Moldovan and D'Andrea, 2009) . In response to replication stress, the FA core complex (comprised of FANCA, B, C, E, F, G, L, and M) catalyzes the monoubiquitylation of the FANCD2/ FANCI heterodimer, which promotes its recruitment to damaged replication forks. Once recruited, FANCD2/FANCI colocalizes with BRCA2 (FANCD1), PALB2 (FANCN), and FANCJ in nuclear repair foci (Kennedy and D'Andrea, 2005; Wang, 2007) . Since FANCJ, BRCA2, and PALB2 are essential for homologous recombination (HR) (Boulton, 2006; D'Andrea and Grompe, 2003; Martin et al., 2005; Petalcorin et al., 2006) , it has been proposed that the FA pathway maintains genomic integrity by facilitating HR-mediated repair, but how this occurs remains unclear.
The nematode C. elegans has emerged as a powerful system for the study of FA in the context of a whole organism (Youds et al., 2009 ). Similar to their vertebrate counterparts, mutants in C. elegans FCD-2 (FANCD2), FNCI-1 (FANCI), DOG-1 (FANCJ), and FCM-1 (FANCM) are exquisitely sensitive to ICLinducing agents and display chromosomal aberrations and enhanced mutagenesis following treatment with these agents (Collis et al., 2006; Muzzini et al., 2008; Youds et al., 2009) . At the molecular level, the C. elegans FCD-2 and FNCI-1 proteins are monoubiquitylated in response to replication stress, and this requires the replication stress checkpoint proteins ATL-1 (ATR), CHK-1 (CHK1), and RPA-1, as well as the FA core complex protein FCM-1 (Collis et al., 2006 (Collis et al., , 2007 Lee et al., 2010) . Once activated, FCD-2 is recruited to nuclear DNA repair foci, demonstrating the conservation of the central elements of the FA pathway (Collis et al., 2006; Lee et al., 2010) .
The C. elegans germline also offers an excellent system to study the repair of double strand breaks (DSBs), which are physiologically generated by the topoisomerase-like protein SPO-11 during meiosis. Meiotic DSBs are preferentially repaired by HR using a parental homolog to form interhomolog crossovers that are essential for accurate chromosome segregation at the first meiotic division (Page and Hawley, 2003) . In wild-type C. elegans, RAD-51 foci, which form at meiotic DSBs, arise during the late zygotene and early pachytene stages, and then rapidly decrease in number during pachytene stage as meiotic DSB repair progresses (Colaiá covo et al., 2003; Rinaldo et al., 2002) . Both timely disappearance of RAD-51 foci at pachytene and establishment of crossovers require the presence of the mismatch repair related proteins MSH-4 and MSH-5 (Kelly et al., 2000; Zalevsky et al., 1999) and the assembly of the synaptonemal complex (SC), a proteinaceous structure that is required to maintain homologous chromosomes in close alignment (Colaiá covo et al., 2003) . In C. elegans, meiotic DSBs are not a prerequisite for SC assembly (Dernburg et al., 1998) , and axis morphogenesis and SC formation are not required for loading of the RAD-51 strand-exchange protein onto DSBs (Colaiá covo et al., 2003; Rinaldo et al., 2002) . These attributes of C. elegans meiosis allow factors that affect synapsis to be distinguished from those required for meiotic DSB repair. For instance, despite a failure to form crossovers, the lack of chromosome fragments in the oocytes of msh-4/5 and SC mutants (syp-1 or syp-2) demonstrates that these mutants retain the ability to repair meiotic DSBs. The repair observed in msh-4/5 and syp-1/2 mutants is most likely achieved by HR repair between sister chromatids. Indeed, recent studies have established that C. elegans BRCA1 (BRC-1), while being dispensable for crossover formation between homologs, is essential for intersister HR repair of meiotic DSBs in SC mutants (Adamo et al., 2008) .
Prompted by the infertility of FA patients (Alter, 1993) and the presence of meiotic defects in FANCD2 knockout mice (Houghtaling et al., 2003) , we have investigated the meiotic role of C. elegans FCD-2. Whereas FCD-2 is dispensable for crossover recombination in normal meiosis, loss of FCD-2 in syp-2 (SC defective) or msh-4 (crossover defective) mutants resulted in erroneous repair of meiotic DSBs, a phenotype that could be suppressed by deleting the DNA ligase component lig-4. Strikingly, eliminating LIG-4 activity also suppressed the ICL-induced defects of fcd-2 mutants to levels indistinguishable from wild-type. Similarly, deletion or inhibition of NHEJ suppressed the ICL sensitivity of FA-deficient mammalian cells. Consistent with a role for the FA pathway in ensuring that DNA lesions are repaired with high fidelity, cells lacking FANCD2 exhibited promiscuous recruitment of DNA-PKcs to sites of replication stress. Our findings reveal that the FA pathway suppresses illegitimate repair of meiotic DSBs and ICL lesions by NHEJ and that inhibition of NHEJ suppresses several FA phenotypes that stem from defects in DNA repair.
RESULTS
Crossovers Occur Normally but Meiotic RAD-51 Foci Are Elevated in fcd-2 Mutants Although FA patients and mouse models of FA have reduced fertility, and FANCD2 has been previously implicated in DNA repair processes, upon initial examination, no apparent meiotic phenotype is detectable in C. elegans fcd-2 mutants. Both the incidence of males (0.04%), reflecting the frequency of X chromosome nondisjunction during meiosis, and the levels of embryonic lethality (0.51%), indicative of missegregation of the autosomes, appear normal in fcd-2 mutants (Collis et al., 2006; Polanowska et al., 2006; this study) . Homolog pairing, synapsis, and chiasmata formation also occur as normal in fcd-2 mutant, indicating that FCD-2 is dispensable for crossing over (Figures 1A and 1B) . To confirm this, we assayed the frequency of recombination in the fcd-2 mutant in two different chromosomal intervals: (1) dpy-5 to unc-29 on chromosome I (a region with a low level of recombination of about 1 cM/Mb), and (2) unc-60 to dpy-11 on chromosome V (an interval with a relatively high recombination frequency of about 3.7 cM/Mb). In both of these intervals the frequency of recombination observed in fcd-2 mutants (3.17% and 20.10%, respectively) was similar to that observed in wild-type worms (Table S1 ). These data indicate that fcd-2 is dispensable for crossover formation in meiosis.
Given the potential link between the FA pathway and HRmediated repair, we also analyzed fcd-2 mutant germlines for HR repair events by immunostaining with anti-RAD-51 antibodies. RAD-51 foci were elevated between the leptotene and pachytene stages of meiotic prophase (Figure 2 and Table S2 ). This result was confirmed in 11C3 [fcd-2] worms ( Figure S1 ), which carry an extrachromosomal fcd-2 transgene array that induces cosuppression of both itself and the endogenous fcd-2 gene . In contrast, animals derived from the 11C3 line that have lost the extrachromosomal array (at a frequency of 43%) do not exhibit increased meiotic RAD-51 foci ( Figure S1 ). Analysis of RAD-51 foci in spo-11;fcd-2 double mutants, in which meiotic DSB formation is impaired, revealed a very similar RAD-51 staining pattern to that of spo-11 mutants. Thus, the increase in RAD-51 foci in fcd-2 mutants might either represent an increase in DSB formation or most likely reflects compromised repair of SPO-11-induced meiotic DSBs, as previously suggested for other DNA repair genes such as msh-4, msh-5, syp-2, or brc-1 (Colaiá covo et al., 2003 , Adamo et al., 2008 . These results establish that loss of fcd-2 leads to accumulation of meiotic RAD-51 foci, which suggest that FCD-2 is required for efficient conversion of HR intermediates into poststrand exchange products in meiosis.
FCD-2 Prevents Illegitimate Repair of Meiotic DSBs in Crossover Deficient Mutants
The accumulation of meiotic RAD-51 foci together with the wildtype levels of crossovers in fcd-2 mutants is highly reminiscent of the meiotic phenotype of brc-1 mutant (Adamo et al., 2008) . BRC-1 is required for the repair of meiotic DSBs using the sister chromatid under circumstances where the homologs are unavailable for repair, such as in SC mutants (syp-2) or in mutants that lack the prointerhomolog crossover protein MSH-4 (Adamo et al., 2008) . Prompted by these observations, we sought to determine if FCD-2 plays a similar role to BRC-1 in intersister repair of meiotic DSBs. In wild-type diakinesis oocytes, six DAPI-stained bodies, or bivalents (representing the six homologs held together by chiasmata) are observed, whereas syp-2 or him-14/MSH4 (hereafter called msh-4) mutant oocytes typically contain 12 unpaired chromosomes (univalents) at diakinesis. In contrast, cytological analysis revealed that the majority of fcd-2; syp-2 double-mutant oocytes possessed between 6 and 12 DAPI-stained bodies ( Figures 1A and 1B) . This phenotype contrasts with the chromosome fragmentation observed in brc-1;syp-2 double mutants (Adamo et al., 2008) . Furthermore, fcd-2; msh-4 double mutant oocytes displayed between 4 and 12 DAPI-stained bodies ( Figures 1A and 1B) .
We reasoned that the presence of between 4 and 12 DAPIstained bodies in fcd-2; syp-2 and fcd-2;msh-4 double-mutant oocytes may reflect noncovalent aggregation of nonhomologous chromosomes, partial restoration of HR-mediated interhomolog repair, or illegitimate repair between nonhomologous chromosomes. To discriminate between these possibilities we used fluorescent in situ hybridization (FISH) to label two different chromosomes (III and V) in fcd-2;syp-2 and fcd-2;msh-4 germlines. Staining of a single DAPI-stained body with both probes would suggest the physical association of chromosome III and chromosome V. As expected, this event was never observed in wild-type (45 nuclei), fcd-2 (75 nuclei), syp-2 (40 nuclei), or msh-4 (45 nuclei) oocytes ( Figure 3A) . However, chromosomes III and V were found in the same DAPI body in oocytes of both fcd-2; syp-2 (6/63) and fcd-2;msh-4 (1/56) double mutants ( Figure 3A ). These (Table S3) . data imply that when crossover formation is impaired, FCD-2 prevents inappropriate engagements between nonhomologous chromosomes at diakinesis.
FCD-2 Is Required to Prevent NHEJ during Meiotic DSB Repair
The presence of nonhomologous chromosome associations in diakinesis oocytes of fcd-2;syp-2 and fcd-2;msh-4 double mutants could be readily explained if meiotic DSBs are repaired inappropriately by nonhomologous end joining (NHEJ) in these mutants. To test this hypothesis, we quantified the number of DAPIstained bodies in diakinesis oocytes of the triple mutants lig-4;fcd-2;syp-2 and lig-4;fcd-2;msh-4 in which NHEJ is abolished by mutation of lig-4, the ligase component that seals the break (Clejan et al., 2006) . Deletion of lig-4 in the fcd-2;syp-2 and fcd-2;msh-4 backgrounds led to a redistribution of the number of DAPI-stained bodies at diakinesis from an average of 4 to 12 bodies in the fcd-2;syp-2 and fcd-2;msh-4 double mutants to predominantly 12 or more than 12 DAPI bodies in both lig-4;fcd-2;syp-2 and lig-4;fcd-2;msh-4 triple mutants ( Figure 3B and Table S3 ). These results suggest that NHEJ is responsible for the association events arising between nonhomologous chromosomes in the fcd-2;syp-2 and fcd-2;msh-4 mutants. It is notable that chromosome fragmentation is also observed in both triple mutants implying that intersister repair is not completely restored by blocking NHEJ. It is therefore possible that FCD-2 is also required for efficient intersister HR repair. Nevertheless, these data support a role for FCD-2 in suppressing the promiscuous use of NHEJ during meiotic DSB repair.
Eliminating LIG-4 Suppresses the ICL Repair Defects of fcd-2 Mutants Our findings in meiosis raised the possibility that the FA pathway may also prevent NHEJ during ICL repair in mitotic cells, which we next sought to examine. Measurement of embryonic survival following treatment with ICL-inducing agents confirmed previous observations that C. elegans fcd-2 mutants are hypersensitive to cisplatin (CDDP), nitrogen mustard (HN2), and UVA-activated trimethylpsoralen (TMP-UVA; Figures 4A, S3A, and S3B). Remarkably, elimination of NHEJ in fcd-2 mutants by deletion of lig-4 rescued the CDDP sensitivity to levels indistinguishable from wild-type ( Figure 4A ). Furthermore, lig-4;fcd-2 double mutants exhibited near wild-type sensitivity following treatment with HN2 or TMP-UVA ( Figures S3A and S3B ). Thus, eliminating LIG-4 is sufficient to suppress the ICL sensitivity of fcd-2 mutants.
It had been previously reported that RAD-51 foci form at sites of ICL lesions independently of FCD-2 (Collis et al., 2006; Lee et al., 2010) . Treatment with HN2 induces extensive accumulation of RAD-51 foci in wild-type, lig-4, fcd-2, and lig-4;fcd-2 double mutants with almost 100% of mitotic nuclei showing RAD-51 foci 12 hr post treatment ( Figure 4B ). Normally, as repair proceeds, RAD-51 foci gradually disappear, and by 48 hr posttreatment the number of foci has returned to levels approaching the wild-type before treatment. In contrast, over 60% of nuclei in the fcd-2 mutant still retain RAD-51 foci at the 48 hr time point, consistent with a defect in ICL repair. Strikingly, eliminating NHEJ by deletion of lig-4 suppressed the persistence of RAD-51 foci in fcd-2 mutants ( Figure 4B ).
Persistence of DNA lesions in the C. elegans germline is sufficient to trigger the DNA-damage checkpoint and induce apoptosis (Gartner et al., 2000) . Consistent with the presence of unresolved RAD-51 foci, fcd-2 mutants displayed much higher levels of apoptosis following CDDP treatment when compared with wild-type or lig-4 mutant worms ( Figure 4C ). Eliminating NHEJ by deletion of lig-4 in the fcd-2 mutant suppressed the ICL-induced germ cell apoptosis to levels comparable to the wild-type ( Figure 4C) . Treatment of C. elegans FA mutants with ICL-inducing agents also leads to the accumulation of chromosomal abnormalities in embryos ( Figure 4D ), similar to the situation in vertebrate FA cells (Collis et al., 2006) . In accordance with our previous data, eliminating NHEJ in fcd-2 mutants by deletion of lig-4 suppressed the frequency of chromosomal abnormalities to near wild-type levels following treatment with TMP-UVA ( Figure 4D ).
It remained possible that the rescue of ICL repair defects in the fcd-2 mutant by deletion of lig-4 could reflect the use of alternate error-prone repair pathways that, while sufficient to rescue sensitivity, may lead to enhanced mutation frequencies. To investigate this possibility, we determined whether eliminating LIG-4 in fcd-2 mutants would suppress or enhance the frequency of postembryonic developmental defects either before or after treatment with ICL-inducing agents. Phenotypic analysis of untreated fcd-2 mutants revealed a low level of postembryonic developmental defects (25/3630) that was Table S2. statistically different from wild-type (0/4587), lig-4 (0/3513), and lig-4;fcd-2 double mutants (7/4133, fcd-2 versus fcd-2;lig-4, p = 0.0007; Figure 4E and Table S4 ). Treatment with CDDP induced postembryonic developmental defects in 31/236 (13.1%) of the surviving progeny of fcd-2 mutants. This phenotype was suppressed to near wild-type or lig-4 levels (9/470 = 1.9% and 12/575 = 2.09%, respectively) in the lig-4; fcd-2 double mutant (6/354 = 1.7%; Figure 4E and Table S4 ). These results suggest that fcd-2 mutants exhibit increased levels of spontaneous as well as ICL-induced developmental abnormalities that are NHEJ dependent.
Blocking NHEJ Substantially Rescues the ICL Repair Defect of FANCD2-Deficient Human Cells
We next set out to determine if the ICL sensitivity of FANCD2-deficient mammalian cells could also be suppressed by blocking NHEJ. For these studies we exploited human MO59K (DNAPKcs proficient) and MO59J (DNA-PKcs deficient) cells ( Figure 5A ), which were derived from a glioblastoma from a single patient in which a reversion mutation restores the reading frame and expression of DNA-PKcs in MO59K cells (Anderson et al., 2001; Galloway and Allalunis-Turner, 2000; Lees-Miller et al., 1995) . DNA-PKcs is a PI3K-like kinase family member found in vertebrates that is recruited to breaks and activated by the KU70/KU80 heterodimer. These proteins, in conjunction with Artemis, XRCC4, and DNA Ligase IV are required for NHEJ (Ma et al., 2005) . As expected, treatment of MO59K cells with FANCD2 siRNAs resulted in sensitivity to mitomycin C (MMC; Figures 5A and 5B) (Timmers et al., 2001 ). Similar to our results in worms, however, DNA-PKcs-deficient MO59J cells depleted for FANCD2 exhibited levels of survival after MMC treatment comparable to controls ( Figures 5A and 5B) .
To further validate these results, we employed a potent and specific DNA-PKcs inhibitor (PKi) NU7026 (Veuger et al., 2003) . While PKi-treated cells exhibited increased sensitivity to ionizing radiation, as previously described (Veuger et al., 2003 ) (58% survival after 2.5 Gy IR, versus 92% survival of untreated controls), addition of PKi had no measurable impact on the MMC sensitivity of control siRNA cells. HeLa cells treated with FANCD2 siRNAs resulted in the expected hypersensitivity to MMC, whereas blocking NHEJ by addition of PKi suppressed the MMC sensitivity of FANCD2 depleted cells to levels comparable to controls ( Figures 5C and 5D) .
We next investigated whether inhibition of NHEJ by another means could suppress the ICL sensitivity of FANCD2-deficient cells. For these studies we opted to treat patient-derived PD733 cells that harbor a mutation in FANCD2 with siRNAs to the KU80 subunit of the Ku heterodimer, which functions as the DNA-binding component of DNA-PK. As expected, PD733 cells exhibited hypersensitivity to MMC when subjected to control siRNA. In contrast, treatment of cells with Ku80 siRNA suppresses the MMC sensitivity of PD733 cells ( Figure S4A ). Collectively, these results indicate that depletion or inhibition of Ku80 or DNA-PKcs is sufficient to substantially rescue the ICL sensitivity of FANCD2-depleted human cells.
Blocking NHEJ Partially Rescues the ICL Repair Defect of FA Core Complex-Deficient Cells Since the FA core complex is responsible for the monoubiquitylation of FANCD2 and FANCI in response to replication stress, we also wished to determine the effect of blocking NHEJ on Table S3. the ICL sensitivity of FA core complex mutants. For these studies, we focused our attention on the FANCA and FANCC subunits of the FA core complex. Treatment of HeLa cells with FANCA siRNAs (Figure 6A ) resulted in the expected sensitivity to MMC, when compared to control ( Figure 6B ). Blocking NHEJ by addition of PKi suppressed the MMC sensitivity of FANCA siRNA-treated cells ( Figure 6B ). To substantiate these findings we also analyzed the impact of blocking NHEJ in mouse knockout MEFs also conferred suppression of MMC sensitivity ( Figures 6C and 6D) . Furthermore, treatment of cells with Ku80 siRNA led to suppression of MMC sensitivity of the FA patient derived cell line PD331, which carry a mutation in FancC ( Figure S4B ). Our results indicate that blocking NHEJ can also suppress the ICL sensitivity of FA core complex-deficient cells.
Inappropriate Accumulation of DNA-PKcs at Sites of Replication Stress Occurs in the Absence of FANCD2
Given that NHEJ factors have a very high affinity for DNA ends, we reasoned that the FA pathway might be required to prevent the inappropriate engagement of these factors with DSB intermediates formed during the ICL repair process. To investigate this possibility, we utilized an antibody raised against phosphorylated serine 2056 (pS2056) on DNA-PKcs that is able to detect DNA-PK at sites of DSBs by immunofluorescence. Importantly, phosphorylation of DNA-PKcs on serine 2056 is induced in response to DSBs generated by ionizing radiation, and is not normally induced by hydroxyurea (HU) (Yajima et al., 2006) . Immunostaining for pS2056 DNA-PKcs revealed low levels of chromatin-associated foci in untreated wild-type human foreskin fibroblasts (HFF) and FANCD2-deficient PD20 cells ( Figures 7A  and 7B ). IR treatment led to the formation of multiple pS2056 DNA-PKcs foci in 100% of HFF and PD20 cells (Figures 7A and 7B) . Consistent with previous studies, pS2056 DNA-PKcs foci were not significantly induced in wild-type cells following treatment with HU (Yajima et al., 2006) . Furthermore, pS2056 DNA-PKcs foci were only moderately induced following treatment with MMC. In contrast, treatment of FANCD2-deficient PD20 cells with either HU or MMC resulted in the accumulation of multiple pS2056 DNA-PKcs foci in 60%-80% of cells, depending on the treatment (Figures 7A and 7B ). As this phosphorylation event on DNA-PKcs is cell-cycle regulated (Chen et al., 2005) , these differences could result from gross changes in cell-cycle distribution between HFF and PD20 cells following exposure to HU or MMC. However, fluorescence activated cell-sorting analysis excluded this possibility as both the control and FANCD2-deficient cells exhibited similar cell-cycle profiles following each of the HU, MMC, and IR treatments ( Figure S6) . Furthermore, the elevated levels of pS2056 foci observed in HU or MMC-treated PD20 cells could not be explained by differences in the number of DSBs generated in response to these agents as the levels of gH2AX foci were comparable between control and FANCD2-deficient cells ( Figure 7C ). Similar results were also obtained in HeLa cells following siRNA depletion of FANCD2 ( Figure S5 ). Collectively, these data indicate that FANCD2 is required to prevent the inappropriate engagement of DNA-PKcs with damaged/stalled replication forks.
DISCUSSION
Here we report that DNA repair defects observed in C. elegans and mammalian cells deficient for FA components can be suppressed by preventing repair by NHEJ. We observed that C. elegans FCD-2 is dispensable for normal meiotic crossover recombination but is required in syp-2 and msh-4 mutants to prevent erroneous repair of meiotic DSBs through NHEJ. Our data suggest that FCD-2 functions to ensure that meiotic DSBs are channeled into HR as opposed to NHEJ repair pathways. Since meiotic RAD-51 foci accumulate in the early phases of meiosis in the fcd-2 mutant and intersister repair is not completely restored in the triple mutants fcd-2;syp-2;lig-4 and fcd-2;msh-4;lig-4, it would appear that not all of the roles of FCD-2 can be rescued by eliminating NHEJ. In particular, we cannot exclude the possibility that FCD-2 may also play a role in promoting efficient DSB repair through intersister HR in meiosis, a function that is unlikely to be rescued by blocking NHEJ. A role during intersister HR would be consistent with previous observations that Fancd2-deficient cells exhibit an approximate 2-fold reduction in HR repair of a site specific DSB in mammalian cells (Nakanishi et al., 2005) .
More strikingly, we demonstrate that eliminating NHEJ leads to substantial rescue of the ICL-induced repair defects of fcd-2 mutants, including ICL sensitivity, persistent RAD-51 foci, damage-induced chromosomal abnormalities, increased apoptosis, and increased postembryonic developmental defects. Currently it is unclear why inappropriate utilization of NHEJ should lead to persistence of RAD-51 foci during ICL repair. Understanding this problem is also compounded by the fact that there is considerable uncertainty about the structure of the replication fork and how DNA lesions alter the fork in vivo. Nevertheless, it is known that HR proteins are recruited to damaged replication forks and it is inferred that there are likely to be at least two substrates for binding of HR factors following processing of an ICL lesion based on published work: (1) ssDNA gaps that are bound by HR proteins in order to protect the nascent strand from degradation, and (2) one-ended DSBs formed following ICL incision, which may also load HR proteins following DSB processing. Based on our findings we believe that FA may counteract NHEJ from inappropriate engagement with one-ended DSBs but not with ssDNA gaps; NHEJ requires a free end to load and does not load onto gaps. HR proteins ''protecting'' ssDNA gaps at the fork are likely to persist until the one-ended DSB is repaired by NHEJ, which may be considerably slower than repair of the lesion by HR in wild-type. Hence, RAD-51 foci associated with ssDNA gaps could persist in fcd-2 mutants following ICL treatment, and this is suppressed by blocking NHEJ.
Our observations in C. elegans are reinforced by results showing that the ICL sensitivity of FANCD2-deficient human cells is also rescued by blocking NHEJ, which we observed through inhibition/deletion of DNA-PKcs or depletion of Ku80. We also demonstrate that the ICL repair defect of FA corecomplex-deficient cells is suppressed by inhibition of NHEJ. It is notable that the level of suppression of MMC sensitivity of FA core complex and FANCD2-deficient cells conferred by blocking NHEJ differs in that we consistently observed partial and substantial levels of suppression for FA core complex and FANCD2 deficiencies, respectively. This difference may reflect the fact that the FA core complex may perform additional roles in ICL repair independent of its role in regulating FANCD2/FANCI, such as ubiquitylaton of other factors important for ICL repair (Matsushita et al., 2005) . It is notable that suppression of ICL repair defects by inhibition of NHEJ is not applicable to all FA genes as the ICL sensitivity of dog-1 mutants (C. elegans FANCJ) (Youds et al., 2008) was neither rescued nor enhanced by the lig-4 mutation ( Figure S3C ). This may reflect the fact that DOG-1 has functions independent of the FA pathway during replication fork repair (Youds et al., 2008) . Finally, we demonstrate that DNAPKcs is promiscuously activated and inappropriately recruited to sites of replication stress in the absence of FANCD2 in human cells. Collectively, our results lead us to propose that DNA repair defects in FA cells arise as a consequence of the misuse of NHEJ during lesion repair in S phase and in meiosis. This hypothesis provides a plausible explanation for many of the observed FA phenotypes (DNA-repair defects and meiotic problems) and is consistent with the suppression of these phenotypes upon elimination of the NHEJ pathway. Such a scenario is also supported by cytological analysis of radial chromosomes in FA cells; over 99% of these events arise as a result of translocations between nonhomologous chromosomes, which is a signature of repair by NHEJ (Newell et al., 2004) .
Our results raise the possibility that FA proteins act to regulate the choice of DSB repair pathway, and we propose two potential models that are consistent with published observations and our current data: (1) FA proteins directly antagonize NHEJ by blocking or displacing NHEJ factors from DSB ends, and/or (2) FA proteins coordinate the processing of meiotic DSBs and ICL lesions to favor HR and disfavor NHEJ. Studies of the ICL repair process have established that DSB intermediates are formed at the replication fork following ICL incision. DSB ends are also believed to arise as a result of replication fork regression, which could be promoted by the helicase/translocase activities of FANCM and/or BLM (Gari et al., 2008) . Given that NHEJ factors are present constitutively throughout the cell cycle and possess a high affinity for DSB ends, one possible explanation for our data is that FA proteins bind to and protect DSB intermediates from engagement and repair by NHEJ. Supporting this idea, in vitro DNA-binding assays indicate that FANCD2 is able to interact with a number of DNA substrates including forked and linear molecules containing double-stranded DNA ends (Park et al., 2005; Roques et al., 2009) . The hypothesis that FANCD2 physically occludes access of NHEJ factors to repair intermediates is consistent with our findings that eliminating NHEJ is sufficient to substantially rescue FANCD2 deficiency in most, if not all, assays and that DNA-PKcs engages inappropriately with sites of replication stress in the absence of FANCD2. Engagement of NHEJ factors with DSB intermediates during S phase may inhibit the processing of DSBs required for loading of HR factors while also promoting illegitimate repair ( Figure 7D ).
Our results are also consistent with an alternate model in which the FA proteins function to coordinate processing of ICL lesions/ DSB intermediates in a way that would favor HR and disfavor NHEJ. Indeed, it is known that the FA core complex associates with the Blooms and MRN complexes (Meetei et al., 2003; Nakanishi et al., 2002; Pichierri et al., 2002; Roques et al., 2009) , which are both implicated in DSB processing (Gravel et al., 2008; Mimitou and Symington, 2008; Zhu et al., 2008) . Therefore, it is possible that the FA pathway may coordinate BLM-and/or MRN-dependent end processing of DSB intermediates arising at damaged replication forks and meiotic DSBs. It is also possible that the FA pathway may recruit other DSB endprocessing activities to promote HR. Ultimately, processing of the DSB to produce a 3 0 single-stranded overhang would provide an optimal substrate for binding by HR factors, while at the same time reducing the affinity of NHEJ factors for these DNA ends. A role for FCD-2/FANCD2 in coordinating ICL processing is also supported by recent observations that FANCD2/FANCI-depleted frog egg extracts are deficient for the initial incision of an ICL lesion present within a synthetic DNA substrate, and this can be rescued by addition of ubiquitylated FANCD2/FANCI (Knipscheer et al., 2009 ). An essential role for FANCD2 in ICL incision is potentially difficult to reconcile with our findings that the phenotypes resulting from FCD-2/FANCD2 deficiency can be rescued by eliminating NHEJ. However, it is entirely possible that in vivo, alternative nucleases process the ICL lesion inappropriately in the absence of FANCD2/FANCI and this produces a substrate for NHEJ. This scenario is consistent with previous observations and our findings (Figures 4 and 6 ) that DSBs are formed at wild-type levels at ICL lesions in vivo in the absence of FANCD2 (Rothfuss and Grompe, 2004) . Moreover, structurespecific nucleases such as MUS81, XPF, and SNM1A (PSO2) have all been implicated in ICL processing in vivo and could process the ICL lesion inappropriately in the absence of FANCD2 (Ciccia et al., 2008; Li et al., 2005) . Additionally, a recent study has shown that the unhooking of an ICL by XPF/ERCC1 is necessary for the stable association of FANCD2 with damaged chromatin in vivo, which questions the requirement for FANCD2 in initial ICL incision (Bhagwat et al., 2009 ). Nevertheless, our data indicate that blocking NHEJ is sufficient to allow the lesion to be repaired effectively in the absence of FANCD2, whether or not the ICL is inappropriately processed at the incision step.
Finally, it is important to mention that our results showing that deletion or inhibition of Ku80 or DNA-PKcs is sufficient to rescue the ICL sensitivity of FANCD2-deficient human cells was not observed in FANCD2/DNA-PKcs double knockout MEFs (Houghtaling et al., 2005) . The most likely reason for this difference is that human DNA-PKcs possesses additional cellular functions that are not shared with its counterparts in other vertebrates, or alternatively inhibition of DNA-PKcs has a different effect to deletion of this kinase (Ruis et al., 2008) . Irrespective of the reason for this difference, our discovery that the defects in FANCD2-deficient human cells can be substantially suppressed by blocking NHEJ raises the possibility that DNA-PKcs inhibitors could be used in a subset of FA patients to delay the onset of solid tumors, which remains the most significant health issue in adult FA patients.
EXPERIMENTAL PROCEDURES Strains
Strains were cultured according to Wood (1988) , experiments were performed at 20 C. The following C. elegans strains were provided by the Caenorhabditis Genetics Center: wild-type strain Bristol N2. AV106 spo-11(ok79)IV/ nT1 [unc-?(n754) (Collis et al., 2006) was generated and provided by Shoehi Mitani of the National Bioresource Project for the nematode, Japan.
Immunolocalization of RAD-51
The anti-RAD-51 antibody was described in Colaiá covo et al. (2003) . DAPI staining, immunostaining, and analysis of meiotic nuclei were performed using whole-mount preparations of dissected gonads as described in Colaiá covo et al. (2003) . Quantitative analysis of RAD-51 foci was performed on Z series of images acquired using a Leica DM6000 fluorescence microscope, Leica DC 350 FX camera under control of Leica LAS AF 6000 software. Optical sections were collected at 0.25 mm increments and a minimum of 100 nuclei per zone of the germline was scored for each genotype. Quantitative analyses of germline RAD-51 foci (Table S2) were analyzed with student's t test for independent samples. Distributions of numbers of DAPI-stained bodies in the different genotypes were analyzed with the c 2 test (Table S3 ).
C. elegans Treatment with ICL-Inducing Agents
Young adult worms were picked and individually cloned on freshly seeded plates containing 180 mM cis-diamminedichloroplatinum(II) (CDDP, Sigma). Each worm was transferred onto a fresh plate every 24 hr, and the eggs laid after 48 and 72 hr were scored. The progeny were scored for embryonic lethality (unhatched eggs) and for organisms with evident postembryonic developmental defects under a dissecting microscope. Untreated controls were singled out and screened at the same time points. Conditions for HN2 and TMP-UVA treatments were performed as previously described (Collis et al., 2006; Youds et al., 2008) .
Cell Culture
All cell culture, RNAi conditions, whole-cell extracts, and immunoblotting were carried out as previously described (Collis et al., 2007) . For survival assays, cells were treated with 0-80ng/ml mitomycin C (MMC; Sigma). Three to four days after damage, survival was assessed using MTT (Sigma). Cells were treated with 0.5 mM DNA-PK inhibitor (NU7026; Tocris BioScience) or vehicle control for 1-2 hr before damage induction. FancA À/À and FancC À/À MEFs were derived from crosses with FancA +/À FancC +/À double heterozygous mice. The control MEFs were derived from a wild-type littermate resulting from the same cross. Six replicas were used per condition for each experiment; the average of four to six independent experiments is shown.
Immunostaining for Phospho-DNA-PKcs and gH2AX Cells were seeded in duplicate on coverslips and treated 24 hr later with either 3 mM HU, 80 ng/ml MMC, or 5Gy IR and fixed 2 hr, 16hr, 30 min, and 30 mins later respectively. Cells were then stained for phospho-DNA-PKcs (Abcam; ab18192, 1:500) and imaged using a DeltaVision microscope as previously described (Collis et al., 2007) . The presence of phospho-DNA-PKcs foci was scored in over 200 cells per coverslip and the percentage of positive (foci-containing) cells was calculated for each experiment. gH2AX staining (Upstate; 05-636, 1:1000) was carried out on cells treated identically to those processed for phosho-DNA-PKcs staining.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, four tables, and Supplemental Experimental Procedures and can be found with this article online at doi:10.1016/j.molcel.2010.06.026.
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